The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Correlation of proteomics and first-line platinum-based chemotherapy in stage III/IV NSCLC in a large single-center cohort.
Thomas Christoph Gauler
Consultant or Advisory Role - Bristol-Myers Squibb; Lilly
Honoraria - Lilly
Lydia Espenhain
No relevant relationships to disclose
Mathias Hoiczyk
Consultant or Advisory Role - Bristol-Myers Squibb
Honoraria - Lilly
Ivonne Nel
No relevant relationships to disclose
Annette Parr
No relevant relationships to disclose
Joanna Roder
Employment or Leadership Position - Biodesix (B)
Martin H. Schuler
No relevant relationships to disclose
Wilfried Ernst Erich Eberhardt
Consultant or Advisory Role - Bristol-Myers Squibb; Lilly
Honoraria - Bristol-Myers Squibb; Lilly
Research Funding - Lilly
Heinrich Roder
Employment or Leadership Position - Biodesix (B)
Andreas Claudius Hoffmann
No relevant relationships to disclose